Literature DB >> 6981181

Population studies of leukocyte-reactive antinuclear antibody and HLA antigens.

T D Kinsella, J Miller, J P Gofton, F B Vasey.   

Abstract

The prevalence of serum leukocyte-reactive antinuclear antibody (LR-ANA) was determined in 31 patients with ankylosing spondylitis (AS), their age-and gender-matched normal controls, and two tribes of 340 West Coast Canadian Indians (Bella Coolas and Haidas). At a serum dilution of 1 : 10, the prevalence of LR-ANA in AS and controls was 45% and 7%, respectively. At 1 : 20 dilution, the prevalence was 23% in AS, 0% in controls, 29% in Bella Coolas and 27% in Haidas. No concordance was found among LR-ANA, HLA-B27 and CREG-B7, and nine HLA-A and seven HLA-B antigens in the Indian tribes. These studies confirm an increased prevalence of LR-ANA in AS and AS kindreds, but the latter association appears to be independent of HLA antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6981181     DOI: 10.1007/BF00541252

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  AN ANTINUCLEAR FACTOR SPECIFIC FOR LEUCOCYTES.

Authors:  V FABER; P ELLING; G NORUP; B MANSA; N I NISSEN
Journal:  Lancet       Date:  1964-08-15       Impact factor: 79.321

2.  HLA-D locus typing in ankylosing spondylitis and Reiter's syndrome.

Authors:  K Kemple; R A Gatti; W Leibold; J Klinenberg; R Bluestone
Journal:  Arthritis Rheum       Date:  1979-04

3.  Characteristics of antinuclear factors in Felty's syndrome.

Authors:  C M Brunner; J S Davis
Journal:  Arthritis Rheum       Date:  1970 Jan-Feb

4.  Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Authors:  J N Rosenberg; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

5.  Increased frequency of leukocyte-reactive antinuclear antibody in patients with ankylosing spondylitis.

Authors:  F B Vasey; T D Kinsella
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

6.  High prevalence of HLA-Cw1 and Cw2 antigens in spondylarthritis.

Authors:  F Kozin; R Duquesnoy; G E Rodey; R W Lightfoot; L M Ryan
Journal:  Arthritis Rheum       Date:  1978 Nov-Dec

7.  Human granulocyte-specific nuclear antigen(s). II. Detection of antigens in human proliferative syndromes.

Authors:  R C Briggs; J T Forbes; L S Hnilica; M M Montiel; D E Thor
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

8.  New granulocyte antigens demonstrated by microgranulocytotoxicity assay.

Authors:  J S Thompson; V L Overlin; J M Herbick; C D Severson; F H Claas; J D Amaro; C P Burns; R G Strauss; J A Koepke
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

9.  HL-A27 and ankylosing spondylitis in B.C. Indians.

Authors:  J P Gofton; A Chalmers; G E Price; C E Reeve
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

10.  Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.

Authors:  M Leirisalo; H Repo; A Tiilikainen; T U Kosunen; O Laitinen
Journal:  Arthritis Rheum       Date:  1980-09
View more
  1 in total

Review 1.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.